Drugs / adipose derived regenerative cells
adipose derived regenerative cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03676569 | Nov 2015 → Apr 2019 | epilepsy | Mossakowski Medical Research Centre Polish Academy of Sciences | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 7
| Date | Issuer | Release |
|---|---|---|
| 2025-07-23 | InGeneron, Inc. | Results InGeneron Publishes Landmark Study Demonstrating Structural Tendon Regeneration with Autologous Cell Therapy System ingeneron.com ↗
The study, titled “ Regeneration of Biomechanically Functional Tendon Tissue Following Injection of Uncultured, Autologous, Adipose-Derived Regenerative Cells [UA-ADRCs] into Partial Achilles Tendon Defects in Rabbits “, provides robust evidence that InGeneron’s cell therapy restores functional tendon architecture, a key milestone in the company’s scientific narrative. |
| 2023-11-13 | InGeneron, Inc. | Results InGeneron Reports Positive Long-Term Results for its Cell Therapy in Partial-Thickness Rotator Cuff Tears ingeneron.com ↗
This long-term follow-up study, conducted over 41 months (3.4 years) post-treatment, showed that ADRCs were not only safe, but also more effective than corticosteroid injections for improving shoulder function and reducing pain in the treated patients. |
| 2021-07-23 | InGeneron, Inc. | Results InGeneron Reports First-In-Human Microscopic Evidence of Adult Tendon Regeneration Following Autologous Stem Cell Treatment ingeneron.com ↗
The publication provides detailed analysis of a tendon biopsy taken from a 66-year-old patient 10 weeks after his own stem cells were harvested and injected into his damaged shoulder tendon using InGeneron’s Transpose® RT System. |
| 2020-04-07 | InGeneron, Inc. | Results InGeneron Announces Publication of Rotator Cuff Feasibility Study ingeneron.com ↗
InGeneron announces publication of favorable results using regenerative cells isolated from patients’ own body fat prepared with the Transpose ® RT System in the Journal of Orthopaedic Surgery and Research . |
| 2019-10-31 | InGeneron, Inc. | Results InGeneron Announces Publication of Preclinical Results for its Cell Therapy in Chronic Ischemic Heart Failure ingeneron.com ↗
The results show that the mean cardiac output increased by 37%, the mean left ventricular mass increased by 29% and the mean relative amount of scar volume of the left ventricular wall decreased by 21% six weeks after treatment with the cells. |
| 2019-03-21 | InGeneron, Inc. | Results InGeneron Announces Publication of Results from First-in-Human Case Report of its Cell Therapy in Bone Regeneration ingeneron.com ↗
Autologous point-of-care regenerative cell therapy shows favorable safety profile and promising histological outcome in clinical case study of guided bone regeneration |
| 2017-09-18 | InGeneron, Inc. | Results InGeneron Announces Publication of Positive Results from Investigator-Initiated Wound Healing Case Series Using Company’s Regenerative Cell Technology ingeneron.com ↗
Within 10 to 25 weeks, 11 out of the 16 patients showed complete wound closure. |
All press releases naming this drug 7 releases
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adipose-derived regenerative cells | “Objective/Purpose. Evaluation of efficacy and safety of autologous adipose-derived regenerative cells (ADRCs) treatment in autoimmune refractory epilepsy.” PMID 32190059 ↗ Jan 2020 |
| Known as | ADRC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03676569 ↗ |
| Known as | ADRCs | “Objective/Purpose. Evaluation of efficacy and safety of autologous adipose-derived regenerative cells (ADRCs) treatment in autoimmune refractory epilepsy.” PMID 32190059 ↗ Jan 2020 |
| Modality | Cell therapy | “ADRC (adipose derived regenerative cells) isolated from adipose tissue consist mesenchymal stem cells that act as tissue repair cells.” NCT03676569 ↗ |
| Route | Intrathecal | “Intrathecal infusions of autologous ADRC obtained after liposuction followed by isolation by Cytori system will be performed.” NCT03676569 ↗ |